4//SEC Filing
Cavanaugh Sarah 4
Accession 0001415889-24-017182
CIK 0000744218other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:17 PM ET
Size
5.9 KB
Accession
0001415889-24-017182
Insider Transaction Report
Form 4
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
Transactions
- Award
Incentive Stock Option (right to buy)
2024-06-13+78,000→ 78,000 totalExercise: $36.43From: 2025-06-13Exp: 2034-06-13→ Common Stock (78,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001709113
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:17 PM ET
- Size
- 5.9 KB